Value Assessments
Healthcare stakeholders are looking to third parties to help evaluate the value of new medical products. But defining value is complicated. Read about efforts to assess product value, including Avalere’s initiative to develop a value framework that incorporates the patient perspective.
Featured Content
Avalere Publishes Manuscript on Validating Preparation for Shared Decision-Making Tool for Advanced Breast Cancer Patients
Avalere’s “Preparation for Shared Decision-Making” (PFSDM) tool aims to help patients with advanced breast cancer (ABC) feel prepared to communicate with their clinicians and engage in decision making aligned with their preferences. The validation study confirms the acceptability and usability of the tool for women with ABC.
Adapting and Validating a Tool To Guide People with Stage III Non-Small Cell Lung Cancer
Avalere used a human-centered design approach to adapt a patient-centered tool to help patients prepare to make treatment decisions with their clinicians.
Avalere Publishes Viewpoint on Personalizing Value in Cancer Care
To achieve the goals of value-based care, the patient voice must be incorporated into clinical decision-making by embedding shared decision-making (SDM) as a routine part of clinical practice.
Avalere Releases Recommendations to Drive More Patient Orientation in Value Assessment Methodology
Avalere published a white paper outlining global recommendations to increase the patient centricity of value assessment framework methodology and application.
Testing Proves Usefulness of Avalere Shared Decision-Making Tool to Women with Advanced Breast Cancer
In 2018, Avalere partnered with CancerCare and Gabrielle Rocque, an oncologist at the University of Alabama Birmingham School of Medicine, to develop the Preparation for Shared Decision Making (PFSDM) tool.
Avalere Partners with Leading Providers and Advocacy Groups to Chart Course for SDM in Cancer Care
Despite recognition that providers should implement shared decision making (SDM) as standard practice, integration of SDM into regular care delivery remains elusive.
Alternative Financing Models for Durable Cures
Transformative medicines, like gene and cell therapies, are beginning to be approved in the US, and more are expected to come.
ICER’s Use of FDA Approval Volume to Calculate Budget Impact Thresholds: A Scenario Analysis
ICER’s reliance on the average number of FDA drug approvals to calculate budget impact thresholds leads to significant variability.
Developing a Shared Decision-Making Tool in Collaboration with Patients and Clinicians
Avalere used a human-centered design approach structured around patient preferences to help guide advanced breast cancer patients.
Avalere Releases Patient-Perspective Value Framework Scoring Methodology Report
Today, Avalere published a technical appendix to the PPVF Version 1.0 methodology report, outlining a quantitative method for incorporating patient preferences into value assessments and healthcare decision making.
Issue Brief: The Promise of Shared Decision-Making in Improving Value in the US Healthcare System
Evidence suggests that shared decision-making can play a role in advancing a value-based care delivery system.
Christie Teigland Contributes to NQF’s Disparities Report
Avalere’s Teigland was selected by the National Quality Forum to participate in the Disparities Standing Committee.
Podcast: Key Differences Within the Patient-Perspective Value Framework
Tune in as our experts discuss the key differences making the the Patient-Perspective Value Framework 1.0 (PPVF) unique compared to value frameworks currently in the market.
Avalere and FasterCures Co-Author Blog Post Featured in Health Affairs
Blog post features key learnings from the Patient-Perspective Value Framework.
Avalere and FasterCures Release Patient-Perspective Value Framework to Incorporate Patient Preferences into Healthcare Treatment Decisions
Today, Avalere and FasterCures published Version 1.0 of the Patient-Perspective Value Framework (PPVF).
FasterCures Commits Seed Funding for Phase Two of Patient-Perspective Value Framework (PPVF) Initiative
This week, FasterCures provided Avalere with a second round of seed funding to test, refine and validate the PPVF.
Initial Analysis of ICER’s Value Framework Update
Today, the Institute for Clinical and Economic Review (ICER) released an updated version of its Value Assessment Framework.
Promoting Shared Decision Making Around Costs to Improve Value
Avalere and the Robert Wood Johnson Foundation Launch Eight Grants to Improve Cost-of-Care Conversations Between Patients and Clinicians.
Deconstructing the Path to Innovation Adoption
During the last week of October, Avalere invited a select group of innovators to breakfasts in Los Angeles and San Francisco to discuss elements of successful adoption of innovative technologies and models of care.
Releasing the Draft Avalere/FasterCures Patient-Perspective Value Framework (PPVF) for Public Input
Avalere and FasterCures released the first deliverable of the Patient-Perspective Value Framework (PPVF) Initiative at the annual Partnering for Cures Conference.